{"jsonapi":{"version":"1.0"},"data":{"type":"recalls","id":"b093b070252c7b79c79d7b4cba1c382e3e1daef07321815693aabaafcf8c94d7","attributes":{"feedName":"fda","feedSource":"fda","title":"Mylan Institutional LLC Initiates Voluntary Nationwide Recall of Levoleucovorin Injection Due to the Presence of Particulate Matter","description":"Mylan Institutional LLC Initiates Voluntary Nationwide Recall of Levoleucovorin Injection Due to the Presence of Particulate Matter","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mylan-institutional-llc-initiates-voluntary-nationwide-recall-levoleucovorin-injection-due-presence","publicationDate":"2019-03-18T04:00:00.000Z","state":"sent","affected":[],"allergens":[],"audience":["professionals"],"categories":["drugs"],"contaminants":["foreign"],"distribution":["AK","AL","AR","AZ","CA","CO","CT","DC","DE","FL","GA","HI","IA","ID","IL","IN","KS","KY","LA","MA","MD","ME","MI","MN","MO","MS","MT","NC","ND","NE","NH","NJ","NM","NV","NY","OH","OK","OR","PA","RI","SC","SD","TN","TX","UT","VA","VT","WA","WI","WV","WY"],"risk":"possible","token":"5d9e68bb8b079e002a25178e"}}}